Watch Ticker

Aerovate Therapeutics, Inc. Common Stock

Go to Aerovate Therapeutics, Inc. Common Stock Website

$93.80

(%)

Live

Previous Close

$93.8

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million

Jade Biosciences, a biotechnology company focused on autoimmune diseases, has completed its merger with Aerovate Therapeutics and raised $300 million in a private placement. The combined company will advance its lead candidate JADE-001 for IgA nephropathy, with plans to enter the clinic in the second half of 2025.

Related tickers: AVTE.

Read Full Article

Prnewswire - Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences

Aerovate Therapeutics announced a special cash dividend of $69.6 million, or an estimated $2.40 per share, in connection with its proposed merger with Jade Biosciences. The dividend is contingent on the closing of the merger, which is expected to occur on or about April 28, 2025.

Related tickers: AVTE.

Read Full Article

Trending Tickers

Please sign in to view